Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases

Molecular and Cellular Neuroscience

Volumn 66, Issue PA, 2015, Pages 29-36

  Xilouri, Maria ^a   Stefanis, Leonidas ^a,b  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chaperone mediated autophagy; LAMP2A; Neurodegeneration; Parkinson's disease; Proteinopathies; Therapeutic target

Indexed keywords

BAG 1 PROTEIN; CELL PROTEIN; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 90; HUNTINGTIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2A; MUTANT PROTEIN; PENTAPEPTIDE; TAU PROTEIN; TRANSCRIPTION FACTOR PAX2; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; CELL COMMUNICATION; CELL DEATH; CELL GROWTH; CHAPERONE-MEDIATED AUTOPHAGY; COMPLEX FORMATION; DEGENERATIVE DISEASE; DENDRITIC CELL; HUMAN; KIDNEY TUBULE CELL; LYSOSOME MEMBRANE; MACROAUTOPHAGY; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84929707134     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2015.01.003     Document Type: Review

References (77)

1. Agarraberes F.A., Dice J.F. A molecular chaperone complex at the lysosomal membrane is required for protein translocation. J. Cell Sci. 2001, 114(Pt 13):2491-2499.
2. Agarraberes F.A., et al. An intralysosomal hsp70 is required for a selective pathway of lysosomal protein degradation. J. Cell Biol. 1997, 137(4):825-834.
3. Alonso A.C., et al. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 1996, 2(7):783-787.
4. Alonso A.D., et al. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(1):298-303.
5. Alvarez-Erviti L., et al. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch. Neurol. 2010, 67:1464-1472.
6. Alvarez-Erviti L., et al. Influence of microRNA deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson's disease. Cell Death Dis. 2013, 4:e545.
7. Anguiano J., et al. Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives. Nat. Chem. Biol. 2013, 9(6):374-382.
8. Backer J.M., Dice J.F. Covalent linkage of ribonuclease S-peptide to microinjected proteins causes their intracellular degradation to be enhanced during serum withdrawal. Proc. Natl. Acad. Sci. U. S. A. 1986, 83(16):5830-5834.
9. Bandyopadhyay U., et al. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol. Cell. Biol. 2008, 28(18):5747-5763.
10. Bandyopadhyay U., et al. Identification of regulators of chaperone-mediated autophagy. Mol. Cell 2010, 39(4):535-547.
11. Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 2003, 361(9369):1642-1644.
12. Bauer P.O., et al. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat. Biotechnol. 2010, 28(3):256-263.
13. Beilina A., et al. Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(7):2626-2631.
14. Chiang H.L., Dice J.F. Peptide sequences that target proteins for enhanced degradation during serum withdrawal. J. Biol. Chem. 1988, 263(14):6797-6805.
15. Chiang H.L., et al. A role for a 70-kiloDalton heat shock protein in lysosomal degradation of intracellular proteins. Science 1989, 246(4928):382-385.
16. Chu Y., et al. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Neurobiol. Dis. 2009, 35(3):385-398.
17. Cuervo A.M., Dice J.F. A receptor for the selective uptake and degradation of proteins by lysosomes. Science 1996, 273(5274):501-503.
18. Cuervo A.M., Dice J.F. Regulation of lamp2a levels in the lysosomal membrane. Traffic 2000, 1(7):570-583.
19. Cuervo A.M., Wong E. Chaperone-mediated autophagy: roles in disease and aging. Cell Res. 2014, 24(1):92-104.
20. Cuervo A.M., et al. Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation. Am. J. Physiol. 1995, 269(5 Pt 1):C1200-C1208.
21. Cuervo A.M., et al. A population of rat liver lysosomes responsible for the selective uptake and degradation of cytosolic proteins. J. Biol. Chem. 1997, 272(9):5606-5615.
22. Cuervo A.M., et al. IkappaB is a substrate for a selective pathway of lysosomal proteolysis. Mol. Biol. Cell 1998, 9(8):1995-2010.
23. Cuervo A.M., et al. Direct lysosomal uptake of alpha 2-microglobulin contributes to chemically induced nephropathy. Kidney Int. 1999, 55(2):529-545.
24. Cuervo A.M., et al. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004, 305(5688):1292-1295.
25. Dice J.F. Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem. Sci. 1990, 15(8):305-309.
26. Dice J.F., et al. A selective pathway for degradation of cytosolic proteins by lysosomes. Semin. Cell Biol. 1990, 1(6):449-455.
27. Dohi E., et al. Hypoxic stress activates chaperone-mediated autophagy and modulates neuronal cell survival. Neurochem. Int. 2012, 60(4):431-442.
28. Finn P.F., et al. Effects of small molecules on chaperone-mediated autophagy. Autophagy 2005, 1(3):141-145.
29. Furuta K., et al. Differential expression of the lysosome-associated membrane proteins in normal human tissues. Arch. Biochem. Biophys. 1999, 365(1):75-82.
30. Gao L., et al. Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease. Antioxid. Redox Signal. 2014, 20(18):2936-2948.
31. Gilks W.P., et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005, 365(9457):415-416.
32. Grant B.D., Donaldson J.G. Pathways and mechanisms of endocytic recycling. Nat. Rev. Mol. Cell Biol. 2009, 10(9):597-608.
33. Houlden H., Singleton A.B. The genetics and neuropathology of Parkinson's disease. Acta Neuropathol. 2012, 124(3):325-338.
34. Iwata A., et al. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(37):13135-13140.
35. Kabuta T., et al. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J. Biol. Chem. 2008, 283(35):23731-23738.
36. Kaushik S., et al. Lysosome membrane lipid microdomains: novel regulators of chaperone-mediated autophagy. EMBO J. 2006, 25(17):3921-3933.
37. Kaushik S., et al. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol. Biol. Cell 2008, 19(5):2179-2192.
38. Kiffin R., et al. Activation of chaperone-mediated autophagy during oxidative stress. Mol. Biol. Cell 2004, 15(11):4829-4840.
39. Kiffin R., et al. Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age. J. Cell Sci. 2007, 120(Pt 5):782-791.
40. Koga H., et al. Constitutive upregulation of chaperone-mediated autophagy in Huntington's disease. J. Neurosci. 2011, 31(50):18492-18505.
41. Lashuel H.A., et al. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 2013, 14(1):38-48.
42. Liu H., et al. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J. 2009, 23(10):3383-3392.
43. Mak S.K., et al. Lysosomal degradation of alpha-synuclein in vivo. J. Biol. Chem. 2010, 285(18):13621-13629.
44. Marin C., Aguilar E. In vivo 6-OHDA-induced neurodegeneration and nigral autophagic markers expression. Neurochem. Int. 2011, 58(4):521-526.
45. Martinez-Vicente M., et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 2008, 118(2):777-788.
46. Massey A.C., et al. Consequences of the selective blockage of chaperone-mediated autophagy. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(15):5805-5810.
47. Murphy K.E., et al. Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease. Brain 2014, 137(Pt 3):834-848.
48. Murphy K.E., Gysbers A.M., Abbott S.K., et al. Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease. Mov. Disord. 2015, (Jan 16).
49. Orenstein S.J., et al. Interplay of LRRK2 with chaperone-mediated autophagy. Nat. Neurosci. 2013, 16(4):394-406.
50. Paisan-Ruiz C., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44(4):595-600.
51. Pang S., et al. Genetic analysis of the LAMP-2 gene promoter in patients with sporadic Parkinson's disease. Neurosci. Lett. 2012, 526(1):63-67.
52. Qi L., et al. The role of chaperone-mediated autophagy in huntingtin degradation. PLoS One 2012, 7(10):e46834.
53. Qin Z.H., et al. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum. Mol. Genet. 2003, 12(24):3231-3244.
54. Rideout H.J., Stefanis L. The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease. Neurochem. Res. 2014, 39(3):576-592.
55. Rothenberg C., Monteiro M.J. Ubiquilin at a crossroads in protein degradation pathways. Autophagy 2010, 6(7):979-980.
56. Rothenberg C., et al. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum. Mol. Genet. 2010, 19(16):3219-3232.
57. Sala G., et al. Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition. Biomed. Res. Int. 2013, 2013:846725.
58. Sala G., et al. Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease. Brain Res. 2014, 1546:46-52.
59. Salvador N., et al. Import of a cytosolic protein into lysosomes by chaperone-mediated autophagy depends on its folding state. J. Biol. Chem. 2000, 275(35):27447-27456.
60. Sarkar S., et al. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 2009, 16(1):46-56.
61. Schneider J.L., et al. Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation. Cell Metab. 2014, 20(3):417-432.
62. Sooparb S., et al. Suppression of chaperone-mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int. 2004, 65(6):2135-2144.
63. Spillantini M.G., et al. Alpha-synuclein in Lewy bodies. Nature 1997, 388(6645):839-840.
64. Spillantini M.G., et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(11):6469-6473.
65. Thompson L.M., et al. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell Biol. 2009, 187(7):1083-1099.
66. Vekrellis K., Stefanis L. Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies. Expert Opin. Ther. Targets 2012, 16(4):421-432.
67. Vogiatzi T., et al. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J. Biol. Chem. 2008, 283(35):23542-23556.
68. Wang Y., et al. Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus. J. Biol. Chem. 2008, 283(8):4766-4777.
69. Wang Y., et al. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum. Mol. Genet. 2009, 18(21):4153-4170.
70. Wing S.S., et al. Proteins containing peptide sequences related to Lys-Phe-Glu-Arg-Gln are selectively depleted in liver and heart, but not skeletal muscle, of fasted rats. Biochem. J. 1991, 275(Pt 1):165-169.
71. Wu G., et al. Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson's disease. Brain Res. 2011, 1394:105-111.
72. Xilouri M., et al. Aberrant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 2009, 4(5):e5515.
73. Xilouri M., et al. Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration. Brain 2013, 136(Pt 7):2130-2146.
74. Xilouri M., et al. Alpha-synuclein and protein degradation systems: a reciprocal relationship. Mol. Neurobiol. 2013, 47(2):537-551.
75. Yang Q., et al. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009, 323(5910):124-127.
76. Zhang C., Cuervo A.M. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat. Med. 2008, 14(9):959-965.
77. Zhou D., et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 2005, 22(5):571-581.